ABCC1 p.Thr550Ala

[switch to full view]
Comments [show]
Publications
PMID: 16415113 [PubMed] Zhang DW et al: "Mutational analysis of polar amino acid residues within predicted transmembrane helices 10 and 16 of multidrug resistance protein 1 (ABCC1): effect on substrate specificity."
No. Sentence Comment
6 Although mutation of Asn1208 was without effect, two of six mutations in TM10, T550A and T556A, modulated the drug resistance profile of MRP1 without affecting transport of leukotriene C4, 17beta-estradiol 17-(beta-D-glucuronide) (E217betaG), and glutathione.
X
ABCC1 p.Thr550Ala 16415113:6:79
status: NEW
Login to comment

7 Mutation T550A increased vincristine resistance but decreased doxorubicin resistance, whereas mutation T556A decreased resistance to etoposide (VP-16) and doxorubicin.
X
ABCC1 p.Thr550Ala 16415113:7:9
status: NEW
Login to comment

48 Mutations T550A, T552A, T556A, Y568A, Y568S, Y568F, Y568W, T570A, and N1208A were generated using the Quikchange Site-Directed Mutagenesis kit (Stratagene, La Jolla, CA).
X
ABCC1 p.Thr550Ala 16415113:48:10
status: NEW
Login to comment

50 Oligonucleotides bearing mismatched bases at the residues to be mutated (underlined) were synthesized by ACGT Corp. with the following sequences: T550A, 5Ј-GTCAGCCGTGGG- CGCCTTCACCTGGGT-3Ј; T552A, 5Ј-CGTGGGCACCTTCGCCTGGGTC- TGCAC-3Ј; T556A, 5Ј-CACCTGGGTCTGCGCGCCCTTTCTGGT-3Ј; Y568A, 5Ј-TGCACATTTGCCGTCGCCGTGACCATTGACGA-3Ј; Y568S, 5Ј-TGCACATTTGCCGTCTCCGTGACCATTGACGA-3Ј; Y568F, 5Ј-TGC- ACATTTGCCGTCTTCGTGACCATTGACGA-3Ј; Y568W, 5Ј-TGCACAT- TTGCCGTCTGGGTGACCATTGACGA-3Ј; T570A, (5Ј-TGCCGTCTACG- TGGCCATTGACGAGAACAAC-3Ј; and N1208A, 5Ј-GCCGTGCGGCTG- GAGTGTGTGGGCGCC-3Ј.
X
ABCC1 p.Thr550Ala 16415113:50:146
status: NEW
Login to comment

147 Substitution T550A reduced resistance to doxorubicin approximately 2-fold and increased resistance to vincristine approximately 4.5-fold, but had no effect on VP-16 resistance.
X
ABCC1 p.Thr550Ala 16415113:147:13
status: NEW
Login to comment

151 We have shown that mutations T550A and T556A both affect the ability of MRP1 to confer drug resistance, whereas mutation Y568A only influenced the transport of E217betaG.
X
ABCC1 p.Thr550Ala 16415113:151:29
status: NEW
Login to comment

206 The increase in resistance to vincristine observed with the T550A mutation may be attributable to the smaller size of the Ala side chain that favors transport of the larger drug.
X
ABCC1 p.Thr550Ala 16415113:206:60
status: NEW
Login to comment

208 Like the T550A mutation, these mutations decreased resistance to VP-16 and increased resistance to vincristine.
X
ABCC1 p.Thr550Ala 16415113:208:9
status: NEW
Login to comment

PMID: 17295059 [PubMed] Chang XB et al: "A molecular understanding of ATP-dependent solute transport by multidrug resistance-associated protein MRP1."
No. Sentence Comment
111 The P557A mutation in TM10 also exhibited significantly reduced transport of five organic anion substrates [75], whereas the other two mutations in TM10, T550A and T556A, modulate the drug resistance profile of MRP1 [78].
X
ABCC1 p.Thr550Ala 17295059:111:154
status: NEW
Login to comment

PMID: 19949927 [PubMed] Chang XB et al: "Molecular mechanism of ATP-dependent solute transport by multidrug resistance-associated protein 1."
No. Sentence Comment
104 Mutations of C43S in TM1 (112); P343A, K332L and K332D in TM6 (113, 114); W445A and P448A in TM8 (113, 115); T550A, T556A and P557A in TM10 (113, 116); N590A, F594A, P595A, N597A, S604A and S605A in TM11 (113, 117, 118); E1089Q, E1089A, E1089L, E1089N, K1092, S1097 and N1100 in TM14 (119, 120); R1197K in TM16 (121); Y1236F, T1241A, T1242A, T1242C, T1242S, T1242L, Y1243F, N1245A, W1246C, W1246A, W1246F, W1246Y or R1249K in TM17 (121-124) significantly affect MRP1 function.
X
ABCC1 p.Thr550Ala 19949927:104:109
status: NEW
Login to comment

PMID: 21701864 [PubMed] de Foresta B et al: "Transverse and tangential orientation of predicted transmembrane fragments 4 and 10 from the human multidrug resistance protein (hMRP1/ABCC1) in membrane mimics."
No. Sentence Comment
61 Mutations resulting in the replacement of two of its threonine residues (T550A and T556A) modulated the drug-resistance profile of hMRP1 and a mutation affecting the tyrosine residue (Y568A) reduced the affinity of hMRP1 for E217bG (Zhang et al. 2006).
X
ABCC1 p.Thr550Ala 21701864:61:73
status: NEW
Login to comment